In addition, neurotransmitter degrading enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and amyloid precursor protein (APP) degrading enzyme, beta-secretase (BACE-1), are the key enzymes, which control the occurrence of AD. This evidence concerns the gene BACE1 and Alzheimer disease.